Prospective study of hepatitis B virus reactivation in patients with hematological malignancies
- Pompili, Maurizio (ORCID:0000-0001-6699-7980)
- Basso, Maria
- Hohaus, Stefan (ORCID:0000-0002-5534-7197)
- Bosco, Giulia
- D'Andrea, Maria Luisa
- Grieco, Antonio (ORCID:0000-0002-0544-8993)
- Laurenti, Luca (ORCID:0000-0002-8327-1396)
- Pagano, Livio (ORCID:0000-0001-8287-928X)
- Rapaccini, Gian Ludovico (ORCID:0000-0002-6467-857X)
- Sica, Simona (ORCID:0000-0003-2426-3465)
- Storti, Sergio (ORCID:0000-0002-4374-3985)
- Landolfi, Raffaele (ORCID:0000-0002-7913-8576)
Publication date
January 2015
DOIAbstract
The best strategy for managing patients with resolved hepatitis B virus infection (HBsAg negative, anti-HBc antibodies positive with or without anti-HBs antibodies) and hematological malignancies under immunosuppressive therapies has not been defined. The aim of this study was to prospectively analyze the risk of hepatitis B virus reactivation in these patients
Add to ORKG